全文获取类型
收费全文 | 3571篇 |
免费 | 277篇 |
国内免费 | 12篇 |
专业分类
耳鼻咽喉 | 14篇 |
儿科学 | 85篇 |
妇产科学 | 49篇 |
基础医学 | 592篇 |
口腔科学 | 39篇 |
临床医学 | 426篇 |
内科学 | 760篇 |
皮肤病学 | 87篇 |
神经病学 | 343篇 |
特种医学 | 94篇 |
外科学 | 499篇 |
综合类 | 20篇 |
一般理论 | 1篇 |
预防医学 | 198篇 |
眼科学 | 120篇 |
药学 | 231篇 |
中国医学 | 5篇 |
肿瘤学 | 297篇 |
出版年
2023年 | 38篇 |
2022年 | 27篇 |
2021年 | 132篇 |
2020年 | 65篇 |
2019年 | 118篇 |
2018年 | 116篇 |
2017年 | 72篇 |
2016年 | 89篇 |
2015年 | 89篇 |
2014年 | 156篇 |
2013年 | 175篇 |
2012年 | 292篇 |
2011年 | 308篇 |
2010年 | 170篇 |
2009年 | 155篇 |
2008年 | 208篇 |
2007年 | 235篇 |
2006年 | 235篇 |
2005年 | 220篇 |
2004年 | 205篇 |
2003年 | 153篇 |
2002年 | 123篇 |
2001年 | 40篇 |
2000年 | 24篇 |
1999年 | 30篇 |
1998年 | 42篇 |
1997年 | 13篇 |
1996年 | 16篇 |
1995年 | 14篇 |
1994年 | 8篇 |
1993年 | 15篇 |
1992年 | 16篇 |
1991年 | 21篇 |
1990年 | 10篇 |
1989年 | 16篇 |
1988年 | 11篇 |
1987年 | 11篇 |
1986年 | 9篇 |
1985年 | 11篇 |
1984年 | 15篇 |
1983年 | 10篇 |
1982年 | 7篇 |
1980年 | 14篇 |
1979年 | 10篇 |
1978年 | 6篇 |
1977年 | 19篇 |
1976年 | 9篇 |
1975年 | 10篇 |
1974年 | 11篇 |
1970年 | 8篇 |
排序方式: 共有3860条查询结果,搜索用时 187 毫秒
51.
Christophe Lechauve Sébastien Augustin Hélène Cwerman-Thibault élodie Reboussin Delphine Roussel René Lai-Kuen Bruno Saubamea José-Alain Sahel Thomas Debeir Marisol Corral-Debrinski 《Molecular therapy》2014,22(6):1096-1109
Neuroglobin (NGB) is considered as an endogenous neuroprotective molecule against stroke, since the protein alleviates the adverse effects of hypoxic and ischemic insults. We previously demonstrated the functional link between NGB and mitochondria since it is required for respiratory chain function. Thus, here, we evaluated the relevance of this effect in the Harlequin (Hq) mouse strain, which exhibits retinal ganglion cell (RGC) loss and optic atrophy due to a respiratory chain complex I (CI) defect. A twofold decrease of NGB amounts was observed in Hq retinas. We constructed a recombinant adeno-associated virus which combines to the mouse NGB open reading frame, its 5′ and 3′UTR, for guarantying mRNA stability and translation capacity. The vector was administrated intravitreally to Hq mice and NGB expression was stable for up to 7 months without negative effect on retinal architecture or function. On the contrary, RGCs and their axons were substantially preserved from degeneration; consequently, CI activity in optic nerves was protected conferring improvements in vision. Hence, we established that NGB prevents respiratory chain impairment, therefore, protecting visual function otherwise compromised by mitochondrial energetic failure. 相似文献
52.
Martine Mazel William Jacot Klaus Pantel Kai Bartkowiak Delphine Topart Laure Cayrefourcq Delphine Rossille Thierry Maudelonde Thierry Fest Catherine Alix-Panabières 《Molecular oncology》2015,9(9):1773-1782
Immune checkpoint regulators such as PD‐L1 have become exciting new therapeutic targets leading to long lasting remissions in patients with advanced malignancies. However, in view of the remarkable costs and the toxicity profiles of these therapies, predictive biomarkers able to discriminate responders from non‐responders are urgently needed. In the present paper, we provide evidence that PD‐L1 is frequently expressed on metastatic cells circulating in the blood of hormone receptor‐positive, HER2‐negative breast cancer patients. We performed western blot, flow cytometry and immunocytochemical analyses to demonstrate the specificity of the PDL1 antibody used in our study and established immunoscores for PDL1 expression on single tumor cells. We then selected sixteen patients with circulating tumor cells (CTCs) using the CellSearch® system and found PD‐L1(+) CTCs in 11 patients (68.8%). The fraction of PD‐L1(+) CTCs varied from 0.2 to 100% in individual patients. This is the first report demonstrating the expression of PD‐L1 on CTCs. The established CTC/PD‐L1 assay can be used for liquid biopsy in future clinical trials for stratification and monitoring of cancer patients undergoing immune checkpoint blockade. 相似文献
53.
54.
Amélie Huynh Le Maux Bernadette Pignol Delphine Behr-Roussel Jean-Luc Blachon Pierre-Etienne Chabrier Sandrine Compagnie Philippe Picaut Jacques Bernabé Fran?ois Giuliano Pierre Denys 《Toxins》2015,7(12):5462-5471
Intradetrusor injections of Botulinum toxin A—currently onabotulinumtoxinA—is registered as a second-line treatment to treat neurogenic detrusor overactivity (NDO). The common clinical practice is 30 × 1 mL injections in the detrusor; however, protocols remain variable and standardization is warranted. The effect of reducing the number of injection sites of Dysport® abobotulinumtoxinA (aboBoNTA) was assessed in the spinal cord-injured rat (SCI). Nineteen days post-spinalization, female rats received intradetrusor injections of saline or aboBoNTA 22.5 U distributed among four or eight sites. Two days after injection, continuous cystometry was performed in conscious rats. Efficacy of aboBoNTA 22.5 U was assessed versus aggregated saline groups on clinically-relevant parameters: maximal pressure, bladder capacity, compliance, voiding efficiency, as well as amplitude, frequency, and volume threshold for nonvoiding contractions (NVC). AboBoNTA 22.5 U significantly decreased maximal pressure, without affecting voiding efficiency. Injected in four sites, aboBoNTA significantly increased bladder capacity and compliance while only the latter when in eight sites. AboBoNTA significantly reduced NVC frequency and amplitude. This preclinical investigation showed similar inhibiting effects of aboBoNTA despite the number of sites reduction. Further studies are warranted to optimize dosing schemes to improve the risk-benefit ratio of BoNTA-based treatment modalities for NDO and further idiopathic overactive bladder. 相似文献
55.
Antonin Levy Cécile Le Péchoux Hitesh Mistry Isabelle Martel-Lafay Andrea Bezjak Delphine Lerouge Laetitia Padovani Paul Taylor Corinne Faivre-Finn 《Journal of thoracic oncology》2019,14(2):294-297
Introduction
The impact of the dose and fractionation of thoracic radiotherapy on the risk of developing brain metastasis (BM) has not been evaluated prospectively in limited stage SCLC patients receiving prophylactic cerebral irradiation (PCI).Methods
Data from patients treated with PCI from the CONVERT trial were analyzed.Results
Four hundred forty-nine of 547 patients (82%) received PCI after completion of chemoradiotherapy. Baseline brain imaging consisted of computed tomographic scans in 356 of 449 patients (79%) and magnetic resonance imaging in 83 of 449 (18%) patients. PCI was delivered to 220 of 273 participants (81%) in the twice-daily (BD) group and 229 of 270 in the once-daily (OD) group (85%; p = 0.49). Total median PCI dose was 25 Gy in both the BD and OD groups (p = 0.74). In patients who received PCI, 75 (17%) developed BM (35 [8%] in OD and 40 [9%] in BD) and 173 (39%) other extracranial progression. In the univariate analysis, gross tumor volume (GTV) was associated with an increased risk of BM (p = 0.007) or other radiological progression events (p = 0.006), whereas in a multivariate analysis both thoracic GTV (tGTV) and ECOG performance score were associated with either progression type. The median overall survival (OS) of patients treated with PCI was 29 months. In the univariate analysis of OS, PCI timing from end of chemotherapy, weight loss of more than 10%, and tGTV were prognostic factors associated with OS. In the multivariate analysis, only tGTV was associated with OS. Delay between end of chemotherapy and PCI was not associated with OS.Conclusions
Patients receiving OD or BD thoracic radiotherapy have the same risk of developing BM. Larger tumors are associated with a higher risk of BM. 相似文献56.
Brandstetter Susanne Pawellek Maja Böhmer Merle M. Köninger Angela Melter Michael Kabesch Michael Apfelbacher Christian 《Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz》2022,65(12):1281-1288
Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz - Mit Beginn der Impfkampagne hat eine neue Phase der Bewältigung der Coronapandemie begonnen. Zulassung und Empfehlung... 相似文献
57.
58.
Flow cytometry minimal residual disease after allogeneic transplant for chronic lymphocytic leukemia 下载免费PDF全文
Caroline Algrin Jean‐Louis Golmard Mauricette Michallet Oumedaly Reman Anne Huynh Aurore Perrot Anne Sirvent Adriana Plesa Véronique Salaun Marie‐Christine Béné Dominique Bories Olivier Tournilhac Hélène Merle‐Béral Véronique Leblond Magali Le Garff‐Tavernier Nathalie Dhedin 《European journal of haematology》2017,98(4):363-370
59.
60.